Szundy Berardo Renata, Rodacki Melanie, Pugliese Bruna S, Roisman Fernanda, Rocha Juliane, Gilban Daniel, Balassiano Bianca, Beltrão Cristine Barboza, Paiva Isla Aguiar, Moreira Juliana Veiga, Luescher Jorge, Campos Ludmila, Coutinho Isabella, Madeira Isabel Rey, da Costa Alessandra S M F, Tannus Lucianne R M, Rodrigues Nádia C P, Zajdenverg Lenita
Hospital Federal dos Servidores do Estado (HFSE) do Rio de Janeiro, Rio de Janeiro, RJ, Brazil.
Universidade Federal do Rio de Janeiro (UFRJ), Hospital Universitário Clementino Fraga Filho. Departamento de Medicina Interna, Seção de Nutrologia e Diabetes, Rio de Janeiro, RJ, Brazil.
J Pediatr (Rio J). 2025 Jul-Aug;101(4):651-656. doi: 10.1016/j.jped.2025.04.001. Epub 2025 May 29.
This study aimed to determine if there was a rise in new T1DM cases in children during the pandemic in a large metropolitan area in Brazil.
The authors conducted a cross-sectional study at five public tertiary care centers that specialize in diabetes in children, comparing all new T1DM cases (ages 0.5-18y) diagnosed from March 2020 to December 2021 (pandemic period, PP) with those from March 2018 to December 2019 (historical period, HP).
There were 167 new cases in the PP compared to 99 in the HP, reflecting a 68.7 % rise, with a notable peak observed in the third quarter of 2020 (p = 0.006). The average age of diagnosis was 8.4 ± 4.2 years in the PP and 7.5 ± 3.6 years in the HP, with no significant difference (p = 0.06). The gender distribution, BMI Z scores, and duration of diabetes symptoms before diagnosis were similar. The incidence of diabetic ketoacidosis (DKA) at onset was elevated but did not increase during the pandemic (62.6 % historical vs. 59.3 % pandemic period). During the PP, 24 % of patients reported symptoms of SARS-CoV-2 infection before the diagnosis of T1DM or at admission, and 13 % (7/53) of tested patients were positive for SARS-CoV-2.
The present findings indicate a significant rise in new T1DM cases among children during the COVID-19 pandemic compared to prior years, without differences in DKA at onset.
本研究旨在确定巴西一个大都市地区在疫情期间儿童新发1型糖尿病(T1DM)病例是否增加。
作者在五家专门诊治儿童糖尿病的公立三级医疗中心开展了一项横断面研究,将2020年3月至2021年12月(疫情期,PP)诊断的所有新发T1DM病例(年龄0.5 - 18岁)与2018年3月至2019年12月(历史期,HP)的病例进行比较。
疫情期有167例新发病例,而历史期为99例,增长了68.7%,在2020年第三季度观察到一个显著峰值(p = 0.006)。疫情期的平均诊断年龄为8.4 ± 4.2岁,历史期为7.5 ± 3.6岁,无显著差异(p = 0.06)。性别分布、BMI Z评分以及诊断前糖尿病症状持续时间相似。发病时糖尿病酮症酸中毒(DKA)的发生率有所升高,但在疫情期间没有增加(历史期62.6% vs. 疫情期59.3%)。在疫情期,24%的患者在诊断T1DM之前或入院时报告有SARS-CoV-2感染症状,13%(7/53)的检测患者SARS-CoV-2呈阳性。
目前的研究结果表明,与前几年相比新冠疫情期间儿童新发T1DM病例显著增加,发病时DKA无差异。